; and (ii) at a site listed in paragraph (3); and (B) was denied before the date of the enactment of this Act. (3) Sites The sites listed in this paragraph are the following: (A) Camp Siebert, Alabama. (B) Fort McClellan, Alabama. (C) Huntsville Arsenal, Alabama. (D) Rocky Mountain Arsenal, Colorado. (E) Naval Research Laboratory, D.C. (F) Bushnell Field, Florida. (G) Great Lakes Naval Training Center, Illinois. (H) Edgewood Arsenal, Maryland. (I) Fort Detrick, Maryland. (J) Naval Research Laboratory, Maryland. (K) Naval Training Center, Bainbridge, Maryland. (L) Horn Island Installation, Mississippi. (M) Camp Crowder, Missouri. (N) Hart’s Island, New York. (O) Camp Lejeune, North Carolina. (P) Charleston, South Carolina. (Q) Dugway Proving Ground, Utah. (R) Toole Army Depot, Utah. (S) Naval Research Laboratory, Virginia. (T) U.S.S. Eagle Boat No. 58. (U) Ondal, India. (V) Fort Clayton, San Jose Island, Panama. (W) Any site the Secretary of Veterans Affairs determines is appropriate. (4) Factors of consideration In making a determination under paragraph (1), the Secretary— (A) shall consider— (i) that contemporaneous records of testing of full-body exposure to a covered substance frequently may be unavailable because such tests were classified or such records were lost or destroyed; (ii) that many veterans were sworn to secrecy following testing described in clause (i); (iii) each statement based on personal knowledge of a veteran who served at a site listed in paragraph (3); (iv) information in the report from the Secretary of Defense under subsection (b)(2); and (v) any evidence the Secretary considers relevant; and (B) may not determine that testing of full-body exposure to a covered substance did not occur at a site based solely on— (i) information contained in the Department of Defense and Department of Veterans Affairs Chemical Biological Warfare Database